Int J Mol Sci. 2026 Sep 11;27(18):8075.doi: 10.3390/ijms27188075.(IF:5.6).

中文速读

本研究探讨Tau过表达通过破坏线粒体稳态导致心肌肥厚,使用Enlight™ Western Blot Substrate(Engreen)进行Western blot检测相关蛋白表达。

质粒DNA

本文使用:增强型ECL发光液Enlight™

查看产品详情(含全部 166 篇文献) →

Tau Overexpression Causes Cardiac Hypertrophy by Disrupting Mitochondrial Homeostasis.

Jingping Xu 1, Yujia Xing 1,2, Qiqi Liu 1,2, Tianle Wang 1, Wenjia Liu 1, Xiao Yang 1,2, Zhenhua Li 1,2, Jian Wang 1,2

Affiliations

  • 1 State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing 102206, China.
  • 2 College of Life Sciences, Hebei University, Baoding 071002, China.

Abstract

Tau is classically defined as a microtubule-associated protein whose dysfunction underpins neurodegenerative disorders. However, its role in cardiac pathophysiology remains elusive despite recent evidence of its cardiac expression. Here, we report that a ~55 kDa Tau-immunoreactive species, which is commonly found in the nervous system, is markedly upregulated in isoproterenol-induced hypertrophic murine hearts, suggesting that this stress-inducible species is associated with maladaptive cardiac remodeling. Forced Tau expression was sufficient to induce hypertrophic growth in cultured cardiomyocytes. Cardiomyocyte-restricted Tau overexpression in transgenic mice recapitulated the progressive trajectory from hypertrophy to overt heart failure. Mechanistically, Tau overexpression triggered excessive mitochondrial fission, leading to mitochondrial dysfunction evidenced by reduced mitochondrial membrane potential, elevated reactive oxygen species, diminished activity of respiratory chain complexes I and IV, and decreased intracellular ATP. Pharmacological inhibition of mitochondrial fission with Mdivi-1 attenuated Tau overexpression-induced cardiomyocyte hypertrophy; taken together, our gain-of-function evidence identifies the ~55 kDa Tau-immunoreactive species as a stress-associated factor that disrupts mitochondrial dynamics to promote cardiac remodeling, and suggests Tau as a potential therapeutic target for cardiac diseases.

Keywords: Cardiac hypertrophy; Tau; therapeutic target; Mitochondrial Homeostasis

https://doi.org/10.3390/ijms27188075

本文使用的产品

增强型ECL发光液Enlight™

已有 166 篇已发表文献

查看产品详情(含全部 166 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单